Topical tacrolimus for the treatment of inflammatory skin diseases

Author： Assmann Till   Homey Bernhard   Ruzicka Thomas  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.7, 2001-07, pp. : 1167-1175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ascomycins: promising agents for the treatment of inflammatory skin diseases

By Paul C.   Graeber M.   Stuetz A.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 1, 2000-01 ,pp. : 69-77

Informa Healthcare

Access to resources Recommend Favorite

Keratinocytes in Inflammatory Skin Diseases

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 329-334

Bentham Science Publishers

Access to resources Recommend Favorite

The use of tacrolimus in the treatment of inflammatory bowel disease

By Chow Dorothy KL   Leong Rupert WL  

Expert Opinion on Drug Safety, Vol. 6, Iss. 5, 2007-09 ,pp. : 479-485

Informa Healthcare

Access to resources Recommend Favorite

Pimecrolimus for the treatment of inflammatory skin disease

By Wolff Klaus   Stuetz Anton  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 643-655

Informa Healthcare

Access to resources Recommend Favorite

Oxidative Stress in Allergic and Inflammatory Skin Diseases

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 4, 2005-08 ,pp. : 517-519

Bentham Science Publishers

Access to resources Recommend Favorite